NAD+ boosting can be a strategy to improve mitochondrial and metabolic function and to protect against various metabolic diseases, such as insulin resistance and T2DM, via SIRTs–PGC-1α. The gene discussed is PPARGC1A; the disease is type 2 diabetes mellitus.